1Department of Ophthalmology and Visual Sciences,University of Alabama at Birmingham Heersink School of Medicine, 2Department of Ophthalmology,University Hospital of Zurich, 3Vitreous Retina Macula Consultants of New York, 4Department of Ophthalmology,New York University Grossman School of Medicine, 5Advancing Sight Network, 6Department of Ophthalmology,University Hospital Bonn
Summary
Laboratory assays can leverage prognostic value from the longitudinal optical coherence tomography (OCT)-based multimodal imaging of age-related macular degeneration (AMD). Human donor eyes with and without AMD are imaged using OCT, color, near-infrared reflectance scanning laser ophthalmoscopy, and autofluorescence at two excitation wavelengths prior to tissue sectioning.
